These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 21245918

  • 1. Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
    Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM.
    PLoS Negl Trop Dis; 2011 Jan 04; 5(1):e932. PubMed ID: 21245918
    [Abstract] [Full Text] [Related]

  • 2. A continuing high incidence of subacute sclerosing panencephalitis (SSPE) in the Eastern Highlands of Papua New Guinea.
    Takasu T, Mgone JM, Mgone CS, Miki K, Komase K, Namae H, Saito Y, Kokubun Y, Nishimura T, Kawanishi R, Mizutani T, Markus TJ, Kono J, Asuo PG, Alpers MP.
    Epidemiol Infect; 2003 Oct 04; 131(2):887-98. PubMed ID: 14596530
    [Abstract] [Full Text] [Related]

  • 3. Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children.
    Lucas KM, Sanders RC, Rongap A, Rongap T, Pinai S, Alpers MP.
    Epidemiol Infect; 1992 Jun 04; 108(3):547-53. PubMed ID: 1601084
    [Abstract] [Full Text] [Related]

  • 4. The upsurge of SSPE--a reflection of national measles immunization status in Pakistan.
    Ibrahim SH, Amjad N, Saleem AF, Chand P, Rafique A, Humayun KN.
    J Trop Pediatr; 2014 Dec 04; 60(6):449-53. PubMed ID: 25232151
    [Abstract] [Full Text] [Related]

  • 5. Subacute Sclerosing Panencephalitis: The Devastating Measles Complication That Might Be More Common Than Previously Estimated.
    Wendorf KA, Winter K, Zipprich J, Schechter R, Hacker JK, Preas C, Cherry JD, Glaser C, Harriman K.
    Clin Infect Dis; 2017 Jul 15; 65(2):226-232. PubMed ID: 28387784
    [Abstract] [Full Text] [Related]

  • 6. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
    Sonia M, Lalit D, Shobha B, Sheffali G, Amandeep S, Veena K, Madhuri B.
    J Commun Dis; 2009 Sep 15; 41(3):161-7. PubMed ID: 22010482
    [Abstract] [Full Text] [Related]

  • 7. Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea.
    Mgone CS, Mgone JM, Takasu T, Miki K, Kawanishi R, Asuo PG, Kono J, Komase K, Alpers MP.
    Trop Med Int Health; 2003 Mar 15; 8(3):219-27. PubMed ID: 12631311
    [Abstract] [Full Text] [Related]

  • 8. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
    Enders-Ruckle G.
    Dev Biol Stand; 1978 Mar 15; 41():195-207. PubMed ID: 381072
    [Abstract] [Full Text] [Related]

  • 9. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V, Dimova P, Belopitova L, Mihailov A, Gatcheva N, Mihneva Z, Todorova M.
    Neuroepidemiology; 2004 Mar 15; 23(5):254-7. PubMed ID: 15316253
    [Abstract] [Full Text] [Related]

  • 10. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y, Nakao T, Ishida N, Konno T, Mizutani H, Fukuyama Y, Sato T, Isomura S, Ueda S, Kitamura I.
    Int J Epidemiol; 1989 Sep 15; 18(3):684-9. PubMed ID: 2807674
    [Abstract] [Full Text] [Related]

  • 11. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis.
    Modlin JF, Jabbour JT, Witte JJ, Halsey NA.
    Pediatrics; 1977 Apr 15; 59(4):505-12. PubMed ID: 850592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
    Bellini WJ, Rota JS, Lowe LE, Katz RS, Dyken PR, Zaki SR, Shieh WJ, Rota PA.
    J Infect Dis; 2005 Nov 15; 192(10):1686-93. PubMed ID: 16235165
    [Abstract] [Full Text] [Related]

  • 14. Risk factors in subacute sclerosing panencephalitis: a case-control study.
    Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL, Ludwig DD.
    Am J Epidemiol; 1980 Apr 15; 111(4):415-24. PubMed ID: 7377184
    [Abstract] [Full Text] [Related]

  • 15. Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua, New Guinea.
    Miki K, Komase K, Mgone CS, Kawanishi R, Iijima M, Mgone JM, Asuo PG, Alpers MP, Takasu T, Mizutani T.
    J Med Virol; 2002 Sep 15; 68(1):105-12. PubMed ID: 12210437
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
    Zilber N, Rannon L, Alter M, Kahana E.
    Neurology; 1983 Dec 15; 33(12):1558-64. PubMed ID: 6685828
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review of the effect of measles vaccination on the epidemiology of SSPE.
    Campbell H, Andrews N, Brown KE, Miller E.
    Int J Epidemiol; 2007 Dec 15; 36(6):1334-48. PubMed ID: 18037676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.